Unilateral galactorrhea associated with low-dose escitalopram

Abstract

Galactorrhea is a rare adverse effect of selective serotonin reuptake inhibitor treatment. We report a 27-year-old woman who developed unilateral breast engorgement with galactorrhea 18 days after initiation of escitalopram (10 mg/day). The symptom remitted 7 days after withdrawal of escitalopram and did not subsequently recur during maintenance therapy with agomelatine (25 mg/day).

Keywords

• Agomelatine
• escitalopram
• galactorrhea
• prolactin
• selective serotonin reuptake inhibitor
• unilateral breast engorgement